Page last updated: 2024-09-03

n-(2-(diethylamino)ethyl)-4-iodobenzamide and Cancer of Eye

n-(2-(diethylamino)ethyl)-4-iodobenzamide has been researched along with Cancer of Eye in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bacin, F; Bonafous, J; Chossat, F; D'Incan, M; Kemeny, JL; Mestas, D; Moins, N; Sillaire-Houtmann, I; Veyre, A1

Trials

1 trial(s) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Cancer of Eye

ArticleYear
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
    Journal francais d'ophtalmologie, 2004, Volume: 27, Issue:1

    Topics: Benzamides; Choroid Neoplasms; Ciliary Body; Conjunctival Neoplasms; Diagnosis, Differential; Eye Neoplasms; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Melanoma; Ophthalmoscopy; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Uveal Neoplasms

2004